Relative risk reduction of 25% on a 2% baseline = 0.25 × 2% = 0.5 percentage points absolute risk reduction. This means the drug reduces stroke from 2% per year to 1.5% per year. While the relative reduction sounds impressive (25%), the absolute reduction is modest. The number needed to treat (NNT)